Ann Clin Neurophysiol.  2023;25(1):19-26. 10.14253/acn.2023.25.1.19.

Autonomic dysfunction in multiple sclerosis and neuromyelitis optica spectrum disorder

• Kwon S
• Min JH

• KMID: 2541818
• DOI: http://doi.org/10.14253/acn.2023.25.1.19

Abstract

Autonomic dysfunction occurs frequently in multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). Patients with either condition may present with autonomic symptoms such as bladder, sexual, cardiovascular, thermoregulatory, and gastrointestinal dysfunction, and fatigue, but autonomic symptoms that affect quality of life are underrecognized in clinical practice. The immunopathogenesis of MS has been considered to be associated with autonomic dysfunction. Applying appropriate treatment strategies for autonomic dysfunction is important to improve the quality of life of patients. Here we review autonomic dysfunction and how this is managed in patients with MS and NMOSD.

Keyword

Autonomic nervous system diseases; Multiple sclerosis; Neuromyelitis optica spectrum disorder; CNS demyelinating autoimmune diseases

Reference

1. Krbot Skorić M, Crnošija L, Gabelić T, Barun B, Adamec I, Junaković A, et al. Autonomic symptom burden can predict disease activity in early multiple sclerosis. Mult Scler Relat Disord. 2019; 28:250–255.

2. Habek M, Crnošija L, Lovrić M, Junaković A, Krbot Skorić M, Adamec I. Sympathetic cardiovascular and sudomotor functions are frequently affected in early multiple sclerosis. Clin Auton Res. 2016; 26:385–393.

3. Cortez MM, Nagi Reddy SK, Goodman B, Carter JL, Wingerchuk DM. Autonomic symptom burden is associated with MS-related fatigue and quality of life. Mult Scler Relat Disord. 2015; 4:258–263.

4. Mutch K, Zhao S, Hamid S, Methley A, Elsone L, Singh G, et al. Bladder and bowel dysfunction affect quality of life. A cross sectional study of 60 patients with aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2015; 4:614–618.

5. Habek M. Immune and autonomic nervous system interactions in multiple sclerosis: clinical implications. Clin Auton Res. 2019; 29:267–275.

6. Saari A, Tolonen U, Pääkkö E, Suominen K, Pyhtinen J, Sotaniemi K, et al. Cardiovascular autonomic dysfunction correlates with brain MRI lesion load in MS. Clin Neurophysiol. 2004; 115:1473–1478.

7. de Seze J, Stojkovic T, Gauvrit JY, Devos D, Ayachi M, Cassim F, et al. Autonomic dysfunction in multiple sclerosis: cervical spinal cord atrophy correlates. J Neurol. 2001; 248:297–303.

8. Hsu CL, Yeh JH, Lau CI. Persistent hyperthermia in a patient with aquaporin-4-antibody-positive neuromyelitis optica spectrum disorder. J Clin Neurol. 2016; 12:515–516.

9. Poppe AY, Lapierre Y, Melançon D, Lowden D, Wardell L, Fullerton LM, et al. Neuromyelitis optica with hypothalamic involvement. Mult Scler. 2005; 11:617–621.

10. Racosta JM, Kimpinski K, Morrow SA, Kremenchutzky M. Autonomic dysfunction in multiple sclerosis. Auton Neurosci. 2015; 193:1–6.

11. Cosentino M, Zaffaroni M, Marino F, Bombelli R, Ferrari M, Rasini E, et al. Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis. J Neuroimmunol. 2002; 133:233–240.

12. Flachenecker P, Reiners K, Krauser M, Wolf A, Toyka KV. Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability. Mult Scler. 2001; 7:327–334.

13. Kodounis A, Stamboulis E, Constantinidis TS, Liolios A. Measurement of autonomic dysregulation in multiple sclerosis. Acta Neurol Scand. 2005; 112:403–408.

14. Habek M, Krbot Skorić M, Crnošija L, Gabelić T, Barun B, Adamec I. Postural orthostatic tachycardia predicts early conversion to multiple sclerosis after clinically isolated syndrome. Eur Neurol. 2017; 77:253–257.

15. Lensch E, Jost WH. Autonomic disorders in multiple sclerosis. Autoimmune Dis. 2011; 2011:803841.

16. Nakipoglu GF, Kaya AZ, Orhan G, Tezen O, Tunc H, Ozgirgin N, et al. Urinary dysfunction in multiple sclerosis. J Clin Neurosci. 2009; 16:1321–1324.

17. Castel-Lacanal E, Gamé X, Clanet M, Gasq D, De Boissezon X, Guillotreau J, et al. Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients. Neurourol Urodyn. 2015; 34:32–36.

18. Sternberg Z. Sympathetic nervous system dysfunction in multiple sclerosis, linking neurodegeneration to a reduced response to therapy. Curr Pharm Des. 2012; 18:1635–1644.

19. Kim YH, Goodman C, Omessi E, Rivera V, Kattan MW, Boone TB. The correlation of urodynamic findings with cranial magnetic resonance imaging findings in multiple sclerosis. J Urol. 1998; 159:972–976.

20. Kragt JJ, Hoogervorst EL, Uitdehaag BM, Polman CH. Relation between objective and subjective measures of bladder dysfunction in multiple sclerosis. Neurology. 2004; 63:1716–1718.

21. Sirbu CA, Mezei RM, Falup-Pecurariu C, Bratu OG, Sirbu AM, Ghinescu MC, et al. Autonomic dysfunctions in multiple sclerosis: challenges of clinical practice (review). Exp Ther Med. 2020; 20:196.

22. Hornby A. The MS sufferer in the community. Nurs Times. 1978; 74:suppl 130–131.

23. Preziosi G, Raptis DA, Raeburn A, Thiruppathy K, Panicker J, Emmanuel A. Gut dysfunction in patients with multiple sclerosis and the role of spinal cord involvement in the disease. Eur J Gastroenterol Hepatol. 2013; 25:1044–1050.

24. el-Maghraby TA, Shalaby NM, Al-Tawdy MH, Salem SS. Gastric motility dysfunction in patients with multiple sclerosis assessed by gastric emptying scintigraphy. Can J Gastroenterol. 2005; 19:141–145.

25. Tepavcevic DK, Kostic J, Basuroski ID, Stojsavljevic N, Pekmezovic T, Drulovic J. The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis. Mult Scler. 2008; 14:1131–1136.

26. Kessler TM, Fowler CJ, Panicker JN. Sexual dysfunction in multiple sclerosis. Expert Rev Neurother. 2009; 9:341–350.

27. Demirkiran M, Sarica Y, Uguz S, Yerdelen D, Aslan K. Multiple sclerosis patients with and without sexual dysfunction: are there any differences? Mult Scler. 2006; 12:209–214.

28. Guo ZN, He SY, Zhang HL, Wu J, Yang Y. Multiple sclerosis and sexual dysfunction. Asian J Androl. 2012; 14:530–535.

29. DasGupta R, Fowler CJ. Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies. Drugs. 2003; 63:153–166.

30. Davis SL, Wilson TE, White AT, Frohman EM. Thermoregulation in multiple sclerosis. J Appl Physiol (1985). 2010; 109:1531–1537.

31. White KD, Scoones DJ, Newman PK. Hypothermia in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1996; 61:369–375.

32. Uhthoff W. Untersuchungen über die bei der multiplen Herdsklerose vorkommenden Angenstörungen. Archiv für Psychiatrie und Nervenkrankheiten. 1890; 21:55–116.

33. Huang M, Morris N, Jay O, Davis S. Thermoregulatory dysfunction in multiple sclerosis patients during moderate exercise in a thermoneutral environment (1104.17). FASEB J. 2014; 28:1104.17.

34. Noronha MJ, Vas CJ, Aziz H. Autonomic dysfunction (sweating responses) in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1968; 31:19–22.

35. Saari A, Tolonen U, Pääkkö E, Suominen K, Jauhiainen J, Sotaniemi KA, et al. Sweating impairment in patients with multiple sclerosis. Acta Neurol Scand. 2009; 120:358–363.

36. Cartlidge NE. Autonomic function in multiple sclerosis. Brain. 1972; 95:661–664.

37. Chaseling GK, Filingeri D, Barnett M, Hoang P, Davis SL, Jay O. Cold water ingestion improves exercise tolerance of heat-sensitive people with MS. Med Sci Sports Exerc. 2018; 50:643–648.

38. Acevedo AR, Nava C, Arriada N, Violante A, Corona T. Cardiovascular dysfunction in multiple sclerosis. Acta Neurol Scand. 2000; 101:85–88.

39. Midaglia L, Juega Mariño JM, Sastre-Garriga J, Rovira A, Vidal-Jordana A, López-Pérez MA, et al. An uncommon first manifestation of multiple sclerosis: Tako-Tsubo cardiomyopathy. Mult Scler. 2016; 22:842–846.

40. Chagnac Y, Martinovits G, Tadmor R, Goldhammer Y. Paroxysmal atrial fibrillation associated with an attack of multiple sclerosis. Postgrad Med J. 1986; 62:385–387.

41. Jurić S, Mišmaš A, Mihić N, Barać AM, Habek M. Newly onset sinus bradycardia in the context of multiple sclerosis relapse. Intern Med. 2012; 51:1121–1124.

42. Sörös P, Hachinski V. Cardiovascular and neurological causes of sudden death after ischaemic stroke. Lancet Neurol. 2012; 11:179–188.

43. Adamec I, Crnošija L, Junaković A, Krbot Skorić M, Habek M. Progressive multiple sclerosis patients have a higher burden of autonomic dysfunction compared to relapsing remitting phenotype. Clin Neurophysiol. 2018; 129:1588–1594.

44. Studer V, Rocchi C, Motta C, Lauretti B, Perugini J, Brambilla L, et al. Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability. Mult Scler J Exp Transl Clin. 2017; 3:2055217317701317.

45. Maciel BC, Gallo Júnior L, Marin Neto JA, Martins LE. Autonomic nervous control of the heart rate during isometric exercise in normal man. Pflugers Arch. 1987; 408:173–177.

46. Damla O, Altug C, Pinar KK, Alper K, Dilek IG, Kadriye A. Heart rate variability analysis in patients with multiple sclerosis. Mult Scler Relat Disord. 2018; 24:64–68.

47. Sander C, Hildebrandt H, Schlake HP, Eling P, Hanken K. Subjective cognitive fatigue and autonomic abnormalities in multiple sclerosis patients. Front Neurol. 2017; 8:475.

48. Bamer AM, Johnson KL, Amtmann D, Kraft GH. Prevalence of sleep problems in individuals with multiple sclerosis. Mult Scler. 2008; 14:1127–1130.

49. Lanza G, Ferri R, Bella R, Ferini-Strambi L. The impact of drugs for multiple sclerosis on sleep. Mult Scler. 2017; 23:5–13.

50. Fleming WE, Pollak CP. Sleep disorders in multiple sclerosis. Semin Neurol. 2005; 25:64–68.

51. Furlan JC. Autonomic dysreflexia following acute myelitis due to neuromyelitis optica. Mult Scler Relat Disord. 2018; 23:1–3.

52. Berry R, Panegyres PK. Peduncular hallucinosis and autonomic dysfunction in anti-aquaporin-4 antibody syndrome. Cogn Behav Neurol. 2017; 30:116–124.

53. Barun B, Adamec I, Lovrić M, Habek M. Postural orthostatic tachycardia syndrome: additional phenotypic feature of neuromyelitis optica spectrum disorder. Neurol Sci. 2014; 35:1623–1625.

54. Crnošija L, Krbot Skorić M, Andabaka M, Junaković A, Martinović V, Ivanović J, et al. Autonomic dysfunction in people with neuromyelitis optica spectrum disorders. Mult Scler. 2020; 26:688–695.

55. Kwon S, Kim YS, Kim J, Kim BJ, Min JH. Clinical and MRI correlates of autonomic dysfunction in neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2020; 43:102215.

56. Vogel ER, Sandroni P, Low PA. Blood pressure recovery from Valsalva maneuver in patients with autonomic failure. Neurology. 2005; 65:1533–1537.